Cholangitis primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cholangitis}} | {{Cholangitis}} | ||
{{CMG}}; {{AE}} {{FH}} | {{CMG}}; {{AE}}{{ADS}}, {{FH}} | ||
==Overview== | ==Overview== | ||
Revision as of 21:15, 15 December 2017
|
Cholangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangitis primary prevention On the Web |
|
American Roentgen Ray Society Images of Cholangitis primary prevention |
|
Risk calculators and risk factors for Cholangitis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2], Farwa Haideri [3]
Overview
Although reestablishing biliary drainage is the main focus of treatment, antibiotics play an important role in the management of cholangitis.
Primary Prevention
- There are no established measures for the primary prevention of cholangitis in otherwise healthy people.
- Treatment of gallstones, tumors, and infestations of parasites may reduce the risk for some people.
- Patients undergoing ERCP should have prophylactic antibiotics.
- Patients with compromised biliary systems prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages[1]